{
    "clinical_study": {
        "@rank": "67121", 
        "arm_group": [
            {
                "arm_group_label": "high dialysate flow, larger dialyzer", 
                "arm_group_type": "Experimental", 
                "description": "high dialysate flow, larger dialyzer"
            }, 
            {
                "arm_group_label": "low dialysate flow, smaller dialyzer", 
                "arm_group_type": "Active Comparator", 
                "description": "low dialysate flow, smaller dialyzer"
            }
        ], 
        "brief_summary": {
            "textblock": "Hemodialysis keeps patients with renal failure alive but does not restore normal health.\n      Retention of chemicals that bind to plasma proteins and are therefore poorly removed by\n      dialysis may contribute to ill health in patients receiving conventional treatment.  This\n      proposal will test the effect of a new method designed to improve the removal of\n      protein-bound solutes during dialysis.  The effects on blood chemical levels of two\n      different dialysis prescriptions will be tested in patients already undergoing nocturnal\n      in-center hemodialysis three times weekly."
        }, 
        "brief_title": "Increasing the Removal of Protein-Bound Solutes During Extended Hours Hemodialysis", 
        "completion_date": {
            "#text": "December 2015", 
            "@type": "Anticipated"
        }, 
        "condition": "End Stage Renal Failure on Dialysis", 
        "condition_browse": {
            "mesh_term": [
                "Kidney Failure, Chronic", 
                "Renal Insufficiency"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  stable on nocturnal in-center dialysis located close to Stanford University and VA\n             Palo Alto\n\n        Exclusion Criteria:\n\n          -  recent use of antibiotics\n\n          -  gastrointestinal disease"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "85 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "24", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "June 27, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01892839", 
            "org_study_id": "MEY0026APR"
        }, 
        "intervention": [
            {
                "arm_group_label": "low dialysate flow, smaller dialyzer", 
                "description": "The subject will receive dialysis on the usual schedule and for the usual time but with a lower than usual dialysate flow and small dialyzer.", 
                "intervention_name": "low dialysate flow, smaller dialyzer", 
                "intervention_type": "Other"
            }, 
            {
                "arm_group_label": "high dialysate flow, larger dialyzer", 
                "description": "The subject will receive dialysis on the usual schedule and for the usual time but with a higher than usual dialysate flow and large dialyzer.", 
                "intervention_name": "high dialysate flow, larger dialyzer", 
                "intervention_type": "Other"
            }
        ], 
        "is_fda_regulated": "No", 
        "lastchanged_date": "July 23, 2013", 
        "location": {
            "facility": {
                "address": {
                    "city": "Stanford", 
                    "country": "United States", 
                    "state": "California", 
                    "zip": "94301"
                }, 
                "name": "Stanford University"
            }
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "2", 
        "official_title": "Increasing the Removal of Protein-Bound Solutes During Extended Hours Hemodialysis", 
        "overall_contact": {
            "last_name": "tim meyer, md", 
            "phone": "650-852-3314"
        }, 
        "overall_official": {
            "affiliation": "PAIRE", 
            "last_name": "Timothy W Meyer, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Not yet recruiting", 
        "oversight_info": {
            "authority": "United States: Institutional Review Board", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "June 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Plasma levels of the chemical p-cresol sulfate", 
            "safety_issue": "No", 
            "time_frame": "Participants will be followed for 2-3 weeks on different  dialysis prescriptions and plasma chemical levels will be measured at the end of this period."
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01892839"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "Palo Alto Institute for  Research and Education, Inc", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Palo Alto Institute for  Research and Education, Inc", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "July 2013", 
        "study_design": "Allocation: Randomized, Intervention Model: Crossover Assignment, Masking: Open Label, Primary Purpose: Basic Science", 
        "study_type": "Interventional", 
        "verification_date": "July 2013"
    }
}